Prevalence and Causes of Vision Loss in China from 1990 to 2019: Findings from the Global Burden of Disease Study 2019

  • Vision loss is an important public health issue in China, but a detailed understanding of national and regional trends in its prevalence and causes, which could inform health policy, has not been available.

  • This study aimed to assess the prevalence, causes, and regional distribution of vision impairment and blindness in China in 1990 and 2019.

  • In 2019, the age-standardised prevalence was 2·57% (uncertainty interval [UI] 2·28–2·86) for moderate vision impairment, 0·25% (0·22–0·29) for severe vision impairment, and 0·48% (0·43–0·54) for blindness in China, which were all below the global average, but the prevalence of moderate and severe vision impairment had increased more rapidly than in other G20 countries from 1990 to 2019.

  • The prevalence of vision loss increased with age, and the main causes of vision loss varied across age groups.

  • The leading causes of vision impairment in China were uncorrected refractive error, cataract, and macular degeneration in both 1990 and 2019 in the overall population.

  • From 1990 to 2019, the number of people with moderate vision impairment increased by 133·67% (from 19·65 to 45·92 million), those with severe vision impairment increased by 147·14% (from 1·89 to 4·67 million), and those with blindness increased by 64·35% (from 5·29 to 8·69 million); in each case, 20·16% of the increase could be explained by population growth.

  • The contributions to these changes by population ageing were 87·22% for moderate vision impairment, 116·06% for severe vision impairment, and 99·22% for blindness, and the contributions by age-specific prevalence were 26·29% for moderate vision impairment, 10·91% for severe vision impairment, and −55·04% for blindness. The prevalence and specific causes of vision loss differed across provinces.

  • Although a comprehensive national policy to prevent blindness is in place, public awareness of visual health needs improving, and reducing the prevalence of moderate and severe vision impairment should be prioritised in future work.

Publication date

June 23, 2021


The Lancet Public Health

Sponsor Institution

China National Key Research and Development Programme and Beijing Municipal Special Funds for Medical Research on Public Welfare Development and Reform


Tingling Xu, Bingsong Wang, Hua Liu, Haidong Wang, Peng Yin, Wenlan Dong, Jianhong Li, Ya Xing Wang, Mayinuer Yusufu, Paul Briant, Nickolas Reinig, Charlie Ashbaugh, Jaimie Adelson, Theo Vos, Rupert Bourne, Ningli Wang, Maigeng Zhou
Share this